POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION Monday, February 28, 2011   —  9:30 AM - 12:00 Noon Exhibit Hall Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... BREAST PATHOLOGY Poster# Title and Authors Itinerary Planner 13 The Comparison of Different Methods of Axillary Lymph Node Analysis in Metastatic Breast Carcinomas. (200) Y Li, P Rajan, S Alia, C Ersahin - Loyola University Medical Center, Maywood, IL Add 14 Lobular Neoplasia in Core Biopsy of Breast: Clinical Implications. (260) JJ Speiser, E Drinka, C Godellas, C Perez, A Salhadar, C Ersahin, J Sinacore, P Rajan - Loyola University, Maywood, IL Add 15 Histopathologic Findings in Prophylactic Mastectomy Specimens: Experience of a Single Institution. (136) IA Czyszczon, S Sahoo - University of Louisville, KY Add 16 Androgen Receptor Expression Is Usually Maintained in Initial Surgically-Resected Breast Cancer Metastases, but Often Lost in Terminal Metastases Found at Autopsy. (127) A Cimino-Mathews, J Hicks, A DeMarzo, BH Park, P Argani - The Johns Hopkins Hospital, Baltimore, MD Add 17 Ductal Carcinoma (DCIS) in Young Women: A Study of the Pathological and Immunohistochemical Features of Pure DCIS in Women <40 Years of Age. (148) H Elwood, H Nassar-Warzecha - The Johns Hopkins Hospital, Baltimore, MD Add 18 The 8p11.2 Amplicon Is Associated with Hormonal Treatment Resistance and a Worse Clinical Outcome: Validation by FISH, aCGH and Gene Expression Profiling. (161) AA Gru, AL Salavaggione, J Snyder, Y Tao, J Hoog, MJ Ellis, C Allred - Washington University School of Medicine, St. Louis, MO Add 19 A Follow-Up Study of 283 Patients Diagnosed with Papillary Lesions of the Breast. (98) H Arabi, S Bandyopadhyay, B Albashiti, H Skeirek, S Yadam, Y Hussein, A Almradi, R Ali-Fehmi - Wayne State Univ, Detroi, MI Add 20 Core Biopsy Diagnosis vs. Excision Diagnosis of Papillary Lesions of the Breast: The Impact of Breast Pathology Subspecialization. (179) K Jakate, M Debrot, FP O'Malley, AM Mulligan - University of Toronto, ON, Canada; St. Michael's Hospital, Toronto, Canada Add 21 Papillomas on Core Needle Biopsy: Analysis of 88 Cases. (224) A Nayak, MZ Gilcrease, LP Middleton, S Carkaci, J Zhang, N Sneige, L Huo - The University of Texas M.D. Anderson Cancer Center, Houston Add 22 Lymphocytic Lobulitis and Type2 and 3 Lobules Are Seen More Frenquently in Prophylactic Mastectomy from Women with BRCA Mutation. (203) AL Lo, SE Mendrinos - NYU School of Medicine, New York, NY Add 23 Long Non-Coding RNA Expression Levels Correlate with Proliferation Index in Breast Carcinoma. (121) KM Chisholm, R Li, Y Wan, HY Chang, RB West - Stanford University School of Medicine, CA Add 24 Comparison of Genomic Instability in Mucinous A and B Carcinomas of the Breast. (248) A Sanchez-Salazar, SR Gunn, I-T Yeh - UTHSCSA, San Antonio, TX Add 25 Organotropism and Prognostic Marker Discordance in Distant Metastases of Breast Carcinoma: Fact or Fiction? A Clinicopathologic Analysis. (261) PE St. Romain, R Madan, OW Tawfik, I Damjanov, F Fan - University of Kansas Medical Center, Kansas City Add 26 Repeating Breast Cancer Prognostic and Predictive Markers. (100) S Bakhtary, KC Jensen - Stanford University Medical Center, CA; Palo Alto Veterans Health Care System, Palo Alto, CA Add 27 Cold Ischemia Time: Effect on HER2 Detection by In-Situ Hybridization and Immunohistochemistry. (236) BP Portier, E Downs-Kelly, JJ Rowe, D Patil, GT Budd, C Lanigan, Z Wang, D Hicks, DL Rimm, RR Tubbs - Cleveland Clinic, OH; Taussig Cancer Institute, Cleveland, OH; University of Rochester, NY; Yale University, New Haven, CT Add 28 Delay to Formalin Fixation Effect on Breast Carcinoma Biomarkers. (232) M Pekmezci, A Salhadar, P Rajan, C Ersahin - Loyola University Medical Center, Maywood, IL Add 29 Distribution of Estrogen Receptor (ER) Staining by Image Analysis in a Large Cohort of Breast Cancer Cases: Results from the Nurses' Health Study. (289) G Williams, R Hu, R Tamimi, L Collins - Beth Israel Deaconess Medical Center, Boston; Channing Laboratory, Brigham and Women's Hospital, Boston Add 30 Is Estrogen Receptor Assessment Necessary in Well Differentiated Invasive Ductal Carcinomas (IDCs) Graded by the Nottingham Combined Histologic Scoring System? (194) AL Klein, JA Hanson, A Goodwin, DL Weaver, AB Ambaye - Fletcher Allen Health Care, Burlington, VT; University of Vermont, Burlington Add 31 Basal Marker Reactivity in Triple Negative Breast Carcinomas Does Not Predict Pathologic Complete Response Following Neoadjuvant Chemotherapy. (195) JA Kraus, S Beriwal, DJ Dabbs, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA Add 32 A Survey of 45 Biomarkers for Basal-Like Breast Cancer. (126) JR Choo, D Gao, S Leung, C Chow, SYH Lau, J Cheng, TO Nielsen - University of British Columbia, Vancouver, Canada Add 33 Poly (ADP-ribose) Polymerase (PARP)-1 Expression in BRCA1-Associated Breast Cancers: Relationship to Estrogen Receptor (ER) Status. (184) JS Kaplan, S Schnitt, L Collins, K Fetten, V Villegas-Bergazzi, KM Sprott, N Tung - Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA; On-Q-ity, Waltham, MA Add 34 Triple Negative Breast Carcinoma in African American vs. Caucasian Populations: Clinicopathologic Parameters, Marker Expression, and Outcome. (263) HC Sullivan, A Adams, GM Oprea, AJ Page, C Cohen - Emory University, Atlanta, GA Add 35 Survivin Expression in Estrogen Receptor-Positive and Triple Negative Invasive Breast Carcinoma: Correlation with Clinicopathologic Features. (108) KD Bohman, C Cohen, HC Sullivan, B Zbytek, AL Adams - Emory University, Atlanta, GA Add 36 EZH2 Expression in Triple Negative Breast Carcinoma. (173) Y Hussein, S Bandyopadhyay, B Albashiti, A Almradi, Z Nahleh, T Jazaerly, H Jaratli, R Ali-Fehmi - Wayne State University, Detroit, MI; Karmanos Cancer Institute, Detroit, MI; Detoit Medical Center, Detroit, MI Add 37 Chromosomal 7 and 17 Polysomy in Triple Negative Invasive Breast Carcinoma. (272) C Velosa, P Storto, JF Silverman, U Krishnamurti - West Penn Hospital, Pittsburgh, PA; Allegheny General Hospital, Pittsburgh, PA Add 38 Claudin-Low Breast Cancer: A Novel Subtype Associated with Basal-Like Phenotype and Metaplastic Breast Cancer. (208) S Lu, K Singh, S Mangray, R Tavares, L Noble, RA DeLellis, - M Resnick, E Yakirevich Alpert Medical School of Brown University, Providence, RI Add 39 Aurora A Kinase (AURKA) Expression and Clinical Outcome in Invasive Mammary Carcinoma. (157) J Garbaini, KA Kim, CE Sheehan, AB Boguniewicz, JS Ross - Albany Medical College, NY Add 40 NYBR1 Expression in Breast and Gynecologic Tract Carcinomas. (291) AH Woodard, J Yu, DJ Dabbs, AV Florea, S Beriwal, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA Add 41 Measurement of Residual Cancer Burden in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Correlation with Biomarker Expression and Molecular Subtypes. (129) A Cockburn, Y Peng, D Euhus, B Haley, V Sarode - University of Texas Southwestern, Dallas Add 42 Classification by Molecular Subtypes of 70 Male Breast Carcinomas According to Immunohistochemical Profile. (156) NE Fuehrer, AM Locante, JS Scow, JC Boughey, SS Shah, CA Reynolds, RE Jimenez - Mayo Clinic, Rochester, MN Add 43 Morphologic and Immunohistochemistry (IHC) Profile of Luminal A Subtype Breast Cancer Patients with Recurrence and Non-Recurrence: A Single Institution Retrospective Review Study with 10 Year Follow-Up. (169) S Hooda, G Carter, A Brufsky, R Jankowitz, P Badve, M Chivukula - University of Pittsburgh Medical Center, PA Add